Literature DB >> 33321876

Development of Porous Polyurethane Implants Manufactured via Hot-Melt Extrusion.

Ioannis Koutsamanis1,2, Martin Spoerk1, Florian Arbeiter3, Simone Eder1, Eva Roblegg1,2.   

Abstract

Implantable drug delivery systems (IDDSs) offer good patient compliance and allow the controlled delivery of drugs over prolonged times. However, their application is limited due to the scarce material selection and the limited technological possibilities to achieve extended drug release. Porous structures are an alternative strategy that can overcome these shortcomings. The present work focuses on the development of porous IDDS based on hydrophilic (HPL) and hydrophobic (HPB) polyurethanes and chemical pore formers (PFs) manufactured by hot-melt extrusion. Different PF types and concentrations were investigated to gain a sound understanding in terms of extrudate density, porosity, compressive behavior, pore morphology and liquid uptake. Based on the rheological analyses, a stable extrusion process guaranteed porosities of up to 40% using NaHCO3 as PF. The average pore diameter was between 140 and 600 µm and was indirectly proportional to the concentration of PF. The liquid uptake of HPB was determined by the open pores, while for HPL both open and closed pores influenced the uptake. In summary, through the rational selection of the polymer type, the PF type and concentration, porous carrier systems can be produced continuously via extrusion, whose properties can be adapted to the respective application site.

Entities:  

Keywords:  extrusion; foam; polymer; pore former; scaffold; thermoplastic polyurethane

Year:  2020        PMID: 33321876      PMCID: PMC7764633          DOI: 10.3390/polym12122950

Source DB:  PubMed          Journal:  Polymers (Basel)        ISSN: 2073-4360            Impact factor:   4.329


  68 in total

Review 1.  Evolution of implantable and insertable drug delivery systems.

Authors:  Lothar W Kleiner; Jeremy C Wright; Yunbing Wang
Journal:  J Control Release       Date:  2014-02-15       Impact factor: 9.776

Review 2.  Hot-melt extrusion in the pharmaceutical industry: toward filing a new drug application.

Authors:  Marta F Simões; Rui M A Pinto; Sérgio Simões
Journal:  Drug Discov Today       Date:  2019-05-25       Impact factor: 7.851

3.  Mathematical modeling of drug delivery from one-layer and two-layer torus-shaped devices with external mass transfer resistance.

Authors:  Ignacio M Helbling; María I Cabrera; Julio A Luna
Journal:  Eur J Pharm Sci       Date:  2011-08-16       Impact factor: 4.384

4.  Investigation of Thermal and Viscoelastic Properties of Polymers Relevant to Hot Melt Extrusion, IV: Affinisol™ HPMC HME Polymers.

Authors:  Simerdeep Singh Gupta; Nayan Solanki; Abu T M Serajuddin
Journal:  AAPS PharmSciTech       Date:  2015-10-28       Impact factor: 3.246

5.  Hydrophilic thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.

Authors:  G Verstraete; J Van Renterghem; P J Van Bockstal; S Kasmi; B G De Geest; T De Beer; J P Remon; C Vervaet
Journal:  Int J Pharm       Date:  2016-04-22       Impact factor: 5.875

Review 6.  Twin-screw extrusion of sustained-release oral dosage forms and medical implants.

Authors:  Xin Feng; Feng Zhang
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

7.  An injection molding process for manufacturing highly porous and interconnected biodegradable polymer matrices for use as tissue engineering scaffolds.

Authors:  Adam Kramschuster; Lih-Sheng Turng
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2010-02       Impact factor: 3.368

8.  Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1.

Authors:  Kavita M Gupta; Serena M Pearce; Azadeh E Poursaid; Hyder A Aliyar; Patrick A Tresco; Mark A Mitchnik; Patrick F Kiser
Journal:  J Pharm Sci       Date:  2008-10       Impact factor: 3.534

9.  Pore formers promoted release of an antifungal drug from functionalized polyurethanes to inhibit Candida colonization.

Authors:  G Donelli; I Francolini; V Ruggeri; E Guaglianone; L D'Ilario; A Piozzi
Journal:  J Appl Microbiol       Date:  2006-03       Impact factor: 3.772

10.  Improved lysozyme stability and release properties of poly(lactide-co-glycolide) implants prepared by hot-melt extrusion.

Authors:  Zahra Ghalanbor; Martin Körber; Roland Bodmeier
Journal:  Pharm Res       Date:  2009-12-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.